1. Abdelwahed MM, Al-sharaky DR, Abdelnaby AS, Kassem HA (2021). The prognostic significance of Cyclin D1 expression in bladder urothelial carcinoma and correlation with clinicopathological parameters. Menoufia Med J 34:1087–1094.
2. Aboushousha T, Hammam O, Helal N, El Dahshan S (2018). Impact of Cyclin D1 and heterogeneous nuclear ribonucleoprotein-K (HnRNP-K) on urinary bladder carcinogenesis. Asian Pac J Cancer Prev 19:513–519.
3. Amer AI, Eid AM (2019). Prognostic significance of Cyclin D1 in urothelial carcinoma; correlation with p53 and clinicopathological parameters. J Am Sci 15:86–91.
4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424.
5. Chen D, Law ME, Theis JD, Gamez JD, Caron LB, Vrana JA et al. (2009). Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders. Am J Surg Pathol 33:720–729.